Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this interventional study is to evaluate the effects of bundle combination of Amway All-plant protein booster with Nutrilite Lifestyle guideline and/or EMS (Electric Muscle Stimulation) device on Osteoarthritis & Sarcopenia in the middle-aged and elderly (50-70 years old) people.
240 eligible participants will be randomly assigned to 4 equal size study groups (ideally 52 for each group will complete the study) in the two study centers in Shanghai, three site visits will be made during the 6 months of study after screening test. All clinical data will be measured /captured on paper CRF(Case Report Form) and then recorded into CTMS(Clinical Trial Data Management System) for analysis and reporting. It's essential that participants should practice with the assigned guideline and device besides taking the products per day.
Researchers will compare the four groups to see if there is significant improvement of Amway study products with bundle combination of Nutrilite Lifestyle guideline and/or EMS on Osteoarthritis & Sarcopenia in the participants.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Bundle Group 1 with Nutrilite Lifestyle | Active Comparator | Amway All-plant protein booster: 450g/bottle, containing the following active ingredients and with the guideline of Nutrilite Lifestyle:
Facility: EMS (electric muscle stimulation) Nutrition Guideline: Nutrilite Lifestyle |
|
| Bundle Group 2 without Nutrilite Lifestyle | Active Comparator | Amway All-plant protein booster: 450g/bottle, containing the following active ingredients:
Facility: EMS (electric muscle stimulation) |
|
| Control Group 1 | Placebo Comparator | Placebo for all-plant protein booster: 450g/bottle, containing the following ingredients: Maltodextrin |
|
| Control Group 2 with Nutrilite Lifestyle | Placebo Comparator | Placebo for all-plant protein booster: 450g/bottle, containing the following ingredients: Maltodextrin Nutrition Guideline: Nutrilite Lifestyle |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bundle Group 1 with Nutrilite Lifestyle | Dietary Supplement | All-plant protein booster: 2 spoons (15g), twice per day. Calcium & Magnesium:3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day. Practice according to Nutrilite Lifestyle Guideline per day. |
| Measure | Description | Time Frame |
|---|---|---|
| Change of Short Physical Performance Battery (SPPB) score from baseline | Change of Short Physical Performance Battery (SPPB) score [0,12] from baseline to day 180 | baseline day 0, day 180 |
| Measure | Description | Time Frame |
|---|---|---|
| Change of WOMAC Questionnaire Scores from baseline | Change of WOMAC Questionnaire Scores from baseline to day 90 and day 180 | baseline day 0, day 90, day 180 |
| Change of Visual Analogue Scale/Score (VAS) from baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Charlie Zhang, MD | SPRIM Medical | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Raison Healthcare Lab | Shanghai | Shanghai Municipality | China | |||
| Raison Healthcare R&D Center |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35317381 | Background | Basat S, Sivritepe R, Ortaboz D, Sevim E, Atay S, Baygul A. The Relationship Between Osteoarthritis and Sarcopenia in Geriatric Diabetic Patients. Sisli Etfal Hastan Tip Bul. 2021 Dec 29;55(4):516-523. doi: 10.14744/SEMB.2021.42890. eCollection 2021. | |
| 36363519 | Background | Zhong J, Xie W, Wang X, Dong X, Mo Y, Liu D, Yao X, Liu B, Deng W, Su Y, Li Y, Wang X. The Prevalence of Sarcopenia among Hunan Province Community-Dwelling Adults Aged 60 Years and Older and Its Relationship with Lifestyle: Diagnostic Criteria from the Asian Working Group for Sarcopenia 2019 Update. Medicina (Kaunas). 2022 Oct 30;58(11):1562. doi: 10.3390/medicina58111562. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Bundle Group 2 without Nutrilite Lifestyle | Dietary Supplement | All-plant protein booster: 2 spoons (15g), twice per day. Calcium & Magnesium:3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day. |
|
| Control Group 1 | Dietary Supplement | Placebo: 2 spoons (15g), twice per day. Placebo for Calcium & Magnesium:3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day. |
|
| Control Group 2 with Nutrilite Lifestyle | Dietary Supplement | Placebo: 2 spoons (15g), twice per day. Placebo for Calcium & Magnesium:3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day. Practice according to Nutrilite Lifestyle Guideline per day. |
|
Change of Visual Analogue Scale/Score (VAS), with range from 0 to 10 (the smaller the score, the better visual result), from baseline to day 90 and day 180
| baseline day 0, day 90, day 180 |
| Change of Chalder Fatigue Scale (CFS) from baseline | Change of Chalder Fatigue Scale (CFS), FS-14, with range from 0 to 14 (the bigger the score, the more fatigue a person feels), from baseline to day 90 and day 180 | baseline day 0, day 90, day 180 |
| Improvement of Fat and Muscle Portions measured by Inbody S10 from baseline | Improvement of Fat and Muscle Portions measured by Inbody S10 from baseline to day 90 and day 180 | baseline day 0, day 90, day 180 |
| Change of Hand & Grip Strength measured by Jamar Smart Hand Dynamometer from baseline | Change of Hand & Grip Strength measured by Jamar Smart Hand Dynamometer from baseline to day 90 and day 180 | baseline day 0, day 90, day 180 |
| Change of bone density measured by DXA Bone Densitometer from baseline | Change of bone density measured by DXA Bone Densitometer from baseline to day 90 and day 180 | baseline day 0, day 90, day 180 |
| Shanghai |
| Shanghai Municipality |
| China |
| 32424600 | Background | Pickering ME, Chapurlat R. Where Two Common Conditions of Aging Meet: Osteoarthritis and Sarcopenia. Calcif Tissue Int. 2020 Sep;107(3):203-211. doi: 10.1007/s00223-020-00703-5. Epub 2020 May 18. |
| 23973339 | Background | De Ceuninck F, Fradin A, Pastoureau P. Bearing arms against osteoarthritis and sarcopenia: when cartilage and skeletal muscle find common interest in talking together. Drug Discov Today. 2014 Mar;19(3):305-11. doi: 10.1016/j.drudis.2013.08.004. Epub 2013 Aug 20. |
| 32008564 | Background | Matada MS, Holi MS, Raman R, Jayaramu Suvarna ST. Visualization of Cartilage from Knee Joint Magnetic Resonance Images and Quantitative Assessment to Study the Effect of Age, Gender and Body Mass Index (BMI) in Progressive Osteoarthritis (OA). Curr Med Imaging Rev. 2019;15(6):565-572. doi: 10.2174/1573405614666181018123251. |
| 36740545 | Background | Smith D, Knapp PK, Wright DC, Hollick DR. Dual Energy X-Ray Absorptiometry (DXA) Extended Femur Scans to Support Opportunistic Screening for Incomplete Atypical Femoral Fractures: A Short Term in-vivo Precision Study. J Clin Densitom. 2023 Apr-Jun;26(2):101352. doi: 10.1016/j.jocd.2022.12.005. Epub 2022 Dec 8. |
| 33781211 | Background | Lee SY, Choo PL, Pang BWJ, Lau LK, Jabbar KA, Seah WT, Chen KK, Ng TP, Wee SL. SPPB reference values and performance in assessing sarcopenia in community-dwelling Singaporeans - Yishun study. BMC Geriatr. 2021 Mar 30;21(1):213. doi: 10.1186/s12877-021-02147-4. |
| 36509296 | Background | Marcos-Pardo PJ, Gonzalez-Galvez N, Carbonell-Baeza A, Jimenez-Pavon D, Vaquero-Cristobal R. GDLAM and SPPB batteries for screening sarcopenia in community-dwelling Spanish older adults: Healthy-age network study. Exp Gerontol. 2023 Feb;172:112044. doi: 10.1016/j.exger.2022.112044. Epub 2022 Dec 9. |
| 11822921 | Background | Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2002 Feb 11;162(3):292-8. doi: 10.1001/archinte.162.3.292. |
| 31229448 | Background | Doshi R, Ostrovsky D. Glucosamine may be Effective in Treating Pain due to Knee Osteoarthritis. Explore (NY). 2019 Jul-Aug;15(4):317-319. doi: 10.1016/j.explore.2019.04.007. Epub 2019 May 4. No abstract available. |
| 33608362 | Background | Train A, Moe S, Allan GM. Are glucosamine and chondroitin natural remedies for osteoarthritis? Can Fam Physician. 2021 Feb;67(2):111. doi: 10.46747/cfp.6702111. No abstract available. |
| 33504484 | Background | Angelides S, Manolios N. Correspondence on 'Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?'. Ann Rheum Dis. 2023 Mar;82(3):e57. doi: 10.1136/annrheumdis-2020-219694. Epub 2021 Jan 27. No abstract available. |
| 33098419 | Background | Welch C, Majid Z, Greig C, Gladman J, Masud T, Jackson T. Interventions to ameliorate reductions in muscle quantity and function in hospitalised older adults: a systematic review towards acute sarcopenia treatment. Age Ageing. 2021 Feb 26;50(2):394-404. doi: 10.1093/ageing/afaa209. |
| 24219006 | Background | Wakabayashi H, Sakuma K. Comprehensive approach to sarcopenia treatment. Curr Clin Pharmacol. 2014 May;9(2):171-80. doi: 10.2174/1574884708666131111192845. |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D055948 | Sarcopenia |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009133 | Muscular Atrophy |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D001284 | Atrophy |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
Not provided
Not provided